Federal Register / Vol. 73, No. 160 / Monday, August 18, 2008 / Notices 48213 

Board of Governors of the Federal Reserve 

System, August 13, 2008. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E8–19080 Filed 8–15–08; 8:45 am] 

BILLING CODE 6210–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Fifth Meeting of the 

Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2020 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of Public Health and Science, 

Office of Disease Prevention and Health 

Promotion. 

ACTION: Notice of Meeting. 

Authority: 42 U.S.C. 217a, Section 222 of 

the Public Health Service Act, as amended. 

The Committee is governed by the provision 

of Public Law 92–463, as amended (5 U.S.C. 

Appendix 2), which sets forth standards for 

the formation and use of advisory 

committees. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

announces the fifth in a series of federal 

advisory committee meetings regarding 

the national health promotion and 

disease prevention objectives for 2020 to 

be held in Washington, DC. This 

meeting will be open to the public. The 

Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2020 will 

review the nation’s health promotion 

and disease prevention objectives and 

efforts to develop goals and objectives to 

improve the health status and reduce 

health risks for Americans by the year 

2020. The Committee will provide to the 

Secretary of Health and Human Services 

advice and consultation for developing 

and implementing the next iteration of 

national health promotion and disease 

prevention goals and objectives and 

provide recommendations for initiatives 

to occur during the initial 

implementation phase of the goals and 

objectives. HHS will use the 

recommendations to inform the 

development of the national health 

promotion and disease prevention 

objectives for 2020 and the process for 

implementing the objectives. The intent 

is to develop and launch objectives 

designed to improve the health status 

and reduce health risks for Americans 

by the year 2020. 

DATES: The Committee will meet for two 

days: September 4, 2008 from 10:30 a.m. 

to 6 p.m. Eastern Daylight Time and 

September 5, 2008 from 10:30 a.m. to 6 

p.m. Eastern Daylight Time. 

ADDRESSES: The meeting will be held 

online, via WebEx software. For detailed 

instructions about how to make sure 

that your windows computer and 

browser is set up for WebEx, please visit 

the ‘‘Secretary’s Advisory Committee’’

page of the Healthy People Web site at: 

http://www.healthypeople.gov/hp2020/ 

advisory/default.asp. 

FOR FURTHER INFORMATION CONTACT: 

Emmeline Ochiai, Designated Federal 

Officer, Secretary’s Advisory Committee 

on National Health Promotion and 

Disease Prevention Objectives for 2020, 

U.S. Department of Health and Human 

Services, Office of Public Health and 

Science, Office of Disease Prevention 

and Health Promotion, 1101 Wootton 

Parkway, Room LL–100, Rockville, MD 

20852, (240) 453–8259 (telephone), 

(240) 453–8281 (fax). Additional 

information is available on the Internet 

at http://www.healthypeople.gov. 

SUPPLEMENTARY INFORMATION: Purpose of 

Meeting: Every 10 years, through the 

Healthy People initiative, HHS leverages 

scientific insights and lessons from the 

past decade, along with the new 

knowledge of current data, trends, and 

innovations to develop the next 

iteration of national health promotion 

and disease prevention objectives. 

Healthy People provides science-based, 

10-year national objectives for 

promoting health and preventing 

disease. Since 1979, Healthy People has 

set and monitored national health 

objectives to meet a broad range of 

health needs, encourage collaborations 

across sectors, guide individuals toward 

making informed health decisions, and 

measure the impact of our prevention 

and health promotion activities. Healthy 

People 2020 will reflect assessments of 

major risks to health and wellness, 

changing public health priorities, and 

emerging issues related to our nation’s 

health preparedness and prevention. 

Public Participation at Meeting: 

Members of the public are invited to 

listen to the online Advisory Committee 

meeting. There will be no opportunity 

for oral public comments during the 

online Secretary’s Advisory Committee 

on National Health Promotion and 

Disease Prevention Objectives for 2020 

meeting. Written comments, however, 

are welcome throughout the 

development process of the national 

health promotion and disease 

prevention objectives for 2020. They can 

be submitted through the Healthy 

People Web site at: http:// 

www.healthypeople.gov/hp2020/ 

comments/ or they can be e-mailed to 

HP2020@hhs.gov. Please note that the 

public comment Web site will be 

updated throughout the Healthy People 

development process, so people should 

return to the site frequently and provide 

their input. 

To listen to the Committee meeting, 

individuals must pre-register to attend 

the Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2020 at the 

Healthy People Web site located at 

http://www.healthypeople.gov. 

Participation in the meeting is limited. 

Registrations will be accepted until 

maximum WebEx capacity is reached 

and must be completed by close of 

business Eastern Daylight Time on 

September 2, 2008. A waiting list will 

be maintained should registrations 

exceed WebEx capacity. Individuals on 

the waiting list will be contacted as 

additional space for the meeting 

becomes available. 

Registration questions may be 

directed to Hilary Scherer at 

HP2020@norc.org (e-mail), (301) 634–

9374 (phone) or (301) 634–9301 (fax). 

Dated: August 12, 2008. 

Carter Blakey, 

Acting Director, Office of Disease Prevention 

and Health Promotion. 

[FR Doc. E8–19103 Filed 8–15–08; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Environmental 

Health (NCEH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), National 

Center for Environmental Health 

announces the following committee 

meeting. 

Name: Advisory Committee on Childhood 

Lead Poisoning Prevention (ACCLPP). 

Times and Dates: October 29, 2008, 12:30 

p.m.–5 p.m., October 30, 2008, 8:30 a.m.–5 

p.m. 

Place: The Westin San Diego, 400 West 

Broadway, San Diego, California 92101 

Telephone: 619–338–3613, fax: 619–239–

4527. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 125 people. 

Purpose: The committee provides advice 

and guidance to the Secretary; the Assistant 

Secretary for Health; and the CDC Director 

regarding new scientific knowledge and 

technologic developments and their practical 

implications for childhood lead poisoning 

prevention efforts. The committee also 

reviews and reports regularly on childhood 


sroberts on PROD1PC70 with NOTICES
48214 Federal Register / Vol. 73, No. 160 / Monday, August 18, 2008 / Notices 

lead poisoning prevention practices and 

recommends improvements in national 

childhood lead poisoning prevention efforts. 

Matter To Be Discussed: Agenda items are 

subject to change as priorities dictate; 

however, the current agenda includes: 

• Discussion on the potential approaches 

to strengthen existing strategies to achieve 

the Healthy People 2010 goal of eliminating 

elevated blood lead levels as a public health 

problem in the United States by 2010; 

• Update on school performance and 

concurrent blood lead levels (BLLs); 

• Discussion on study designs related to 

adverse effects from BLLs <10 μg/dL; 

• Discussion on the development of a 

prevention-based research agenda. 

Opportunities will be provided during the 

meeting for oral comments. Depending on the 

time available and the number of requests, it 

may be necessary to limit the time for each 

presenter. 

FOR FURTHER INFORMATION CONTACT: 

Claudine Johnson, Program Operations 

Assistant, telephone: 770–488–3629 or 

Barry Brooks, Administrative Team 

Leader, telephone: 770–488–3641, 

Division of Environmental Emergency 

Health Services, National Center for 

Environmental Health, Centers for 

Disease Control and Prevention, 4770 

Buford Hwy, Mailstop F–60, Atlanta, 

Georgia 30341 telephone: 770–488–

3300, fax: 770–488–3635. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: August 7, 2008. 

Daniel Riedford, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E8–19044 Filed 8–15–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; Prostate, Lung, 

Colorectal and Ovarian Cancer 

Screening Trial (PLCO) (NCI) 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Cancer Institute (NCI), the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request to review and approve 

the information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on June 6, 2008, Volume 73, 

Number 110, Page 32338 and allowed 

60 days for public comment. In response 

to the notice, there were no public 

comments received. The purpose of this 

notice is to allow an additional 30 days 

for public comment. The National 

Institutes of Health may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

Proposed Collection: Title: Prostate, 

Lung, Colorectal and Ovarian Cancer 

Screening Trial (PLCO). Type of 

Information Collection Request: 

REVISION (OMB #: 0925–0407, current 

expiry date 10/31/2008). Need and Use 

of Information Collection: This trial is 

designed to determine if screening for 

prostate, lung, colorectal and ovarian 

cancer can reduce mortality from these 

cancers which currently cause an 

estimated 254,900 deaths annually in 

the U.S. The design is a two-armed 

randomized trial of men and women 

aged 55 to 74 at entry. OMB first 

approved this study in 1993 and has 

approved it every 3 years since then 

through 2008. During the first approval 

period a pilot study was conducted to 

evaluate recruitment methods and data 

collection procedures. Recruitment was 

completed in 2001 and data collection 

continues through 2008. When 

participants enrolled in the trial they 

agreed to be followed for at least 13 

years from the time of enrollment. The 

current number of respondents in the 

study is 136, 341; this is down from the 

total initially due to deaths. The 

primary endpoint of the trial is cancerspecific mortality for each of the four 

cancer sites (prostate, lung, colorectum, 

and ovary). In addition, cancer 

incidence, stage shift, and case survival 

are to be monitored to help understand 

and explain results. Biologic prognostic 

characteristics of the cancers will be 

measured and correlated with mortality 

to determine the mortality predictive 

value of these intermediate endpoints. 

Basic demographic data, risk factor data 

for the four cancer sites and screening 

history data, as collected from all 

subjects at baseline, will be used to 

assure comparability between the 

screening and control groups and make 

appropriate adjustments in analysis. 

Further, demographic and risk factor 

information may be used to analyze the 

differential effectiveness of screening in 

high versus low risk individuals. 

Frequency of Response: Annually. 

Affected Public: Individuals. Type of 

Respondents: Adult men and women. 

The estimated total annual burden 

hours requested is 11,401. The 

annualized cost to respondents is 

estimated at $219,919 per year, for a 

total of $659,756 over the proposed 

three year renewal. There are no Capital 

Costs to report. There are no Operating 

or Maintenance Costs to report. 

TABLE A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Survey 

instrument 

Number of 

respondents 

Frequency of 

response 

Average time 

per response 

(hours) 

Total annual 

burden hours 

Male and Female Participants ............................................. ASU 133,341.00 1.00 5/60 11,111.75 

HSQ 1,333.33 1.00 5/60 111.08 

Male Participants ................................................................. Prostate 1,066.67 1.00 10/60 177.83 

Total .............................................................................. ........................ ........................ ........................ ........................ 11,400.66 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 


sroberts on PROD1PC70 with NOTICES